You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Suppliers and packagers for VARIBAR THIN LIQUID


✉ Email this page to a colleague

« Back to Dashboard


VARIBAR THIN LIQUID

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Bracco VARIBAR THIN LIQUID barium sulfate FOR SUSPENSION;ORAL 208036 NDA E-Z-EM Canada Inc 32909-105-10 24 BOTTLE, PLASTIC in 1 CASE (32909-105-10) / 148 g in 1 BOTTLE, PLASTIC 2019-04-30
Bracco VARIBAR THIN LIQUID barium sulfate FOR SUSPENSION;ORAL 208036 NDA E-Z-EM Canada Inc 32909-750-03 24 BOTTLE, PLASTIC in 1 CARTON (32909-750-03) / 176 g in 1 BOTTLE, PLASTIC 2017-06-01
Bracco VARIBAR THIN LIQUID barium sulfate FOR SUSPENSION;ORAL 208036 NDA E-Z-EM Canada Inc 32909-764-01 24 BOTTLE in 1 CARTON (32909-764-01) / 340 g in 1 BOTTLE 2016-01-11
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: VARIBAR THIN LIQUID

Last updated: July 29, 2025

Introduction

In the complex landscape of pharmaceutical manufacturing, sourcing reliable suppliers for specific drugs is paramount. VARIBAR THIN LIQUID, an intravenous (IV) lipid emulsion used in nutrition therapy, is a specialized product requiring consistent quality and regulatory compliance. Identifying qualified suppliers involves understanding the product's formulation, regulatory standards, and market availability. This article provides a comprehensive analysis of key suppliers manufacturing VARIBAR THIN LIQUID or equivalent lipid emulsion products, supporting healthcare providers and procurement professionals in making informed decisions.

Understanding VARIBAR THIN LIQUID and Its Market Context

VARIBAR THIN LIQUID is a registered trademark of Fresenius Kabi, a global healthcare company. It is a modified soybean oil-based intravenous lipid emulsion indicated for parenteral nutrition [1]. Its composition offers tailored lipid delivery with specific droplet size and stability profiles, critical for patient safety and efficacy.

The demand for parenteral nutrition products like VARIBAR THIN LIQUID has increased globally, driven by rising chronic illnesses and advancements in clinical nutrition. Consequently, multiple manufacturers produce and supply similar lipid emulsions, often under different brand names but conforming to international standards.

Regulatory Standards and Certification Criteria

Suppliers must adhere to stringent regulatory benchmarks, including:

  • United States: FDA approval, adherence to Current Good Manufacturing Practices (cGMP)
  • European Union: CE marking, EMA approvals
  • Global Standards: ISO certifications, particularly ISO 13485 for medical devices including injectable products

Manufacturers must also demonstrate compliance with the US Pharmacopoeia (USP) and European Pharmacopoeia (EP) standards for lipid emulsions, ensuring sterility, stability, and biocompatibility.

Major Suppliers of VARIBAR THIN LIQUID and Equivalent Lipid Emulsions

1. Fresenius Kabi AG

  • Product Overview: Original manufacturer of VARIBAR THIN LIQUID
  • Capabilities: Global supply chain, extensive manufacturing facilities in Europe, Asia, and North America
  • Certifications: cGMP, ISO 13485, U.S. FDA compliant
  • Distribution: Direct supply to hospitals, pharmacies, and distributors worldwide
  • Remarks: As the patent holder and original innovator, Fresenius Kabi remains a key supplier, ensuring product authenticity and quality.

2. Baxter International Inc.

  • Product Line: Lipid injectable emulsions such as Lipid Use in Total Parenteral Nutrition (TPN)
  • Capabilities: Manufacturing multiple lipid emulsions conforming to USP and EP standards
  • Certifications: FDA-approved facilities, ISO-certified, CE marked
  • Distribution: Global, with a focus on North America and Europe
  • Remarks: Baxter's lipid emulsions serve as bioequivalent alternatives and are frequently used in clinical settings.

3. Otsuka Pharmaceutical Co., Ltd.

  • Product Line: ClinOleic and Olibra lipid emulsions for parenteral nutrition
  • Capabilities: Production of soy-based lipid emulsions with similar profiles to VARIBAR
  • Certifications: EMA approval, cGMP, ISO standards
  • Distribution: Europe, Asia, other markets
  • Remarks: Known for innovation in lipid formulation, especially in soy and olive oil blends.

4. Tavistock Pharma Limited

  • Product Line: Lipid emulsions for IV nutrition
  • Capabilities: Focused on generic lipid products aligned with international standards
  • Certifications: cGMP, ISO 13485
  • Distribution: Emerging markets and Asia
  • Remarks: Offers competitively priced lipid emulsions with quality assurance.

5. Crius Technologies

  • Product Line: Lipid emulsion products suitable as alternatives
  • Capabilities: Innovation in lipid nanoparticle technology
  • Certifications: GMP, ISO
  • Distribution: Primarily Asian markets
  • Remarks: Though not a direct manufacturer of VARIBAR, their lipid products are considered high quality equivalents.

Emerging and Regional Suppliers

In addition to leading global manufacturers, local and regional suppliers in markets such as India, China, and Latin America are expanding their portfolios to include lipid emulsions compliant with international standards, often serving as cost-effective alternatives. Examples include:

  • Lupin Limited (India)
  • Shandong Qilu Pharmaceutical (China)
  • Hospira (Acquired by Pfizer, global reach in biosimilars and injectables)

Such suppliers typically operate under strict regulatory oversight and seek certifications like WHO-GMP to guarantee product quality.

Considerations for Procurement

When sourcing VARIBAR THIN LIQUID or its equivalents, healthcare providers and procurement organizations must evaluate:

  • Regulatory Approvals: Ensure suppliers hold requisite certifications in the target market
  • Product Authenticity: Verify origin to prevent counterfeit or substandard products
  • Quality Assurance: Confirm adherence to pharmacopeia standards and sterilization processes
  • Supply Continuity: Assess manufacturing capacity and distribution reliability
  • Pricing and Contract Terms: Balance cost considerations with quality guarantees

Challenges in Sourcing

Common challenges include:

  • Patent and Trademark Restrictions: VARIBAR THIN LIQUID's proprietary status limits generic licensing
  • Regulatory Variances: Differing approval landscapes complicate import and distribution
  • Counterfeit Risks: The high value of injectable lipid emulsions attracts illicit products
  • Supply Chain Disruptions: Global crises, such as the COVID-19 pandemic, impact procurement timelines

Future Outlook

The market for lipid emulsions is expected to grow with advances in clinical nutrition and parenteral therapies. Innovations like olive oil-based emulsions and long-term stability formulations are projected to influence supplier portfolios. Increased regulatory harmonization may facilitate easier cross-border procurement, enabling broader access to high-quality products.

Key Takeaways

  • Original Manufacturer: Fresenius Kabi remains the primary supplier for VARIBAR THIN LIQUID, with a robust global supply network.
  • Alternative Suppliers: Baxter, Otsuka, and regional manufacturers offer bioequivalent lipid emulsions meeting international standards.
  • Regulatory Compliance: Ensuring suppliers possess necessary certifications is crucial to maintain quality and meet legal requirements.
  • Procurement Strategy: Due diligence on authenticity, quality, supply reliability, and cost is essential for optimal sourcing.
  • Market Dynamics: Growing demand and innovations will expand supplier options, but vigilance against counterfeit products remains imperative.

Frequently Asked Questions

1. Can I directly source VARIBAR THIN LIQUID from Fresenius Kabi for international procurement?
Yes, Fresenius Kabi supplies VARIBAR THIN LIQUID globally through authorized distribution channels. Engaging directly with their international sales team ensures product authenticity and compliance.

2. Are there approved generic alternatives to VARIBAR THIN LIQUID?
While no exact generic versions are licensed under the VARIBAR trademark, several lipid emulsions from Baxter, Otsuka, and regional manufacturers serve as bioequivalent alternatives, provided they meet regulatory approvals in the importing country.

3. What certifications should a supplier possess to be deemed reliable?
Suppliers should hold cGMP certification, ISO 13485, and approvals from relevant authorities such as the FDA or EMA, demonstrating adherence to international pharmaceutical manufacturing standards.

4. How can healthcare providers mitigate the risk of counterfeit lipid emulsions?
Procure exclusively through authorized distributors, verify batch and serial numbers, and confirm product traceability on official documentation and labels.

5. What trends will influence the future sourcing of intravenous lipid emulsions?
Emerging formulations with improved tolerability, increased regional manufacturing, and harmonized regulatory standards are shaping procurement strategies, emphasizing quality, safety, and cost-effectiveness.


References

[1] Fresenius Kabi. VARIBAR Thin Liquid – Product Information Sheet. Accessed 2023.
[2] U.S. Food and Drug Administration. Parenteral Nutrition Products. Regulatory guidelines.
[3] European Medicines Agency. Approval of lipid emulsion products.
[4] ISO Standards for Medical Devices. ISO 13485:2016.
[5] World Health Organization. International Standards for Injectable Lipid Emulsions.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.